HomeApproved Treatments

Santhera Announces Approval in Hong Kong for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy

Approved Treatments

Santhera Pharmaceuticals announces that the Department of Health of Hong Kong, China, has approved AGAMREE® (vamorolone) for use in patients aged 4 years and older.

Read More

Previous article
Researchers Discover 18-Digit Code (Wnt7a) that Allows Proteins to Hitch a Ride Around the Body
Next article
UK Approves Givinostat (Duvyzat) for Duchenne Muscular Dystrophy Treatment

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Hot Topics

Load more

Related Articles

About us

We do not want children to die from a disease that can be cured. We want to give hope to families and ensure that all children with DMD are treated and regain their health.

Latest Articles

UK Approves Givinostat (Duvyzat) for Duchenne Muscular Dystrophy Treatment

Approved Treatments 0
Givinostat conditionally approved to treat patients with Duchenne muscular...

Researchers Discover 18-Digit Code (Wnt7a) that Allows Proteins to Hitch a Ride Around the Body

Research 0
Researchers from the University of Ottawa and The Ottawa...

Frequently Asked Questions About Elevidys Used for Duchenne Muscular Dystrophy

DMD 0
A genetic condition known as Duchenne muscular dystrophy (DMD)...

Most Popular

Frequently Asked Questions About Elevidys Used for Duchenne Muscular Dystrophy

DMD 0
A genetic condition known as Duchenne muscular dystrophy (DMD)...

Capricor Therapeutics Submits Application for Treatment of DMD Cardiomyopathy

Research 0
Capricor Therapeutics, a biotechnology company developing transformative cell and...

Cure of Duchenne (Research Overview)

Research 0
Dystrophin Gene Therapy Mechanism Company Drug Status Micro-dystrophin Gene Replacement Sarepta Therapeutics Elevidys/SRP-9001 Approved Micro-dystrophin Gene Replacement Pfizer PF-06939926 Discontinued Micro-dystrophin Gene...

© 2024 DMD Warrior. All rights reserved.